Purpose
To leverage existing opportunities to end outbreaks of circulating vaccine-derived poliovirus type 1 by integrating bivalent oral polio vaccine into other supplementary immunization activities in the Africa region.
Grantee
Division
Global Development
Date
SEPTEMBER 2024
Region served
AFRICA,
GLOBAL
Committed amount
$1,661,756
Grant topic
Polio
Duration (months)
11
Grantee location
Brazzaville, Congo
Program strategy page
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.